Perfil de la empresa · Healthcare

Mayinglong Pharmaceutical Group Co Ltd

600993 · Shanghái
País / Región
China
Fecha de salida a bolsa
23 de abril de 2004
Empleados
2544
Buffett Score
72/100
Sólida
Capitalización9707,33 M CNY
Ingresos (TTM)3929,33 M CNY
EBITDA710,27 M CNY
Margen neto15,29 %
ROE14,16 %
PER (TTM)16,2
PER previsto23,42
BPA1,39 CNY
Rentabilidad por dividendo3,15 %
Rango de 52 semanas21,22 CNY – 30,18 CNY

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosmetics, and Chinese medicines; produces and sells health food; and offers class I and II medical devices, machinery, household goods, electronic products, daily necessities, hygiene products, and disinfection products, as well as road freight transportation services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.

Aún no hay análisis sobre este valor en tu idioma.